Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-34
Closed -$959 – 841
2026
Q1
$959 Sell
34
-1,603
-98% -$42.7K ﹤0.01% 388
2025
Q4
$41K Buy
1,637
+556
+51% +$14K 0.01% 152
2025
Q3
$27.5K Sell
1,081
-20
-2% -$494 0.01% 143
2025
Q2
$26.7K Buy
1,101
+1,098
+36,600% +$25.6K 0.01% 155
2025
Q1
$32.1K Sell
3
-1,186
-100% -$31K 0.02% 149
2024
Q4
$31.5K Buy
+1,189
New +$32.3K 0.02% 145

Other funds holding PFE

Curio Wealth's PFE Position: Q2 2026 in Review

Curio Wealth sold out of Pfizer (PFE) in Q2 2026, closing a stake of 34 shares — an estimated $959 sold.

Curio Wealth first reported a position in PFE in Q4 2024 and held it in 6 quarters. The position peaked at $41K in Q4 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Curio Wealth reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Curio Wealth sold 34 Pfizer shares in Q2 2026, an estimated $959.
  • Curio Wealth first reported a position in Pfizer in Q4 2024 and held it in 6 quarters.
  • Curio Wealth's Pfizer position peaked at $41K in Q4 2025.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.